Health Care Deal News, March 3, 2014 - Consolidation Continues in the eHealth Sector, The Pharmaceutical Sector has Been Busier Than Usual in Recent Months, Clinical Research Organizations (CROs) Continue to Attract Investors’ Attention

 

Brought to you by www.DealSearchOnline.com
 

March 3, 2014 Issue:

 

Recent Health Care M&A Deals

Managed Care

 

 

Acquirer

Target

Price

Illinois Health Partners

Northwest Community Healthcare

N/A

Medical Devices

 

 

Syneron Medical

New Star Lasers

$7 million

Pharmaceuticals

 

 

CU Chemie Uetikon GmbH

Amino Acid Building Blocks

N/A

Verastem, Inc.

Rights to VS-4718

$1.44 million

Physician Medical Groups

 

 

MEDNAX, Inc.

Great Lakes Anesthesia Associates, P.C.

N/A

 

Technology Deal of the Week
Consolidation continues in the eHealth sector. Greenway Medical Technologies (NYSE: GWAY), which was taken private last September by Vitera Healthcare Solutions, LLC, made its first public acquisition last week. Greenway, known for its PrimeSUITE© practice management and EHR product, paid an undisclosed amount for PeopleLYNK. The Fort Myers, Florida-based target focuses on patient engagement, allowing healthcare providers to interact with patients via text, email, secure email and voice calls.......Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.

 

Charted Territory
The Pharmaceutical sector has been busier than usual in recent months, especially among specialty pharmaceutical players. So far this year, three $1 billion-plus deals have been announced. One of those topped $25 billion, accounting for the majority of the $30.5 billion already committed to transactions in the space.  ocompany managed to be the target and the acquirer in two of those big deas: Forest Laboratories, Inc. (NYSE: FRX) was acquired by Actavis plc (NYSE: ACT) having just announced its own acquisition of privately held Aptalis Pharma for $2.9 billion in January 2014. And that’s just the first two months. 


Top Five Pharmaceutical Transactions in 2014, through Feb. 28

Rank

Acquirer

Target

Price

1

Actavis plc

Forest Laboratories, Inc.

$25.0 billion

2

Forest Laboratories, Inc.

Apatalis Pharma

$2.9 billion

3

Mallinckrodt plc

Cadence Pharmaceuticals

$1.3 billion

4

Par Pharmaceutical

JHP Pharmaceuticals, LLC

$490 million

5

Valeant Pharmaceuticals

PreCision Dermatology

$475 million

Source: The Health Care M&A News, February 2014

Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today

 

Services Deal of the Week
Clinical research organizations (CROs) continue to attract investors’ attention, as pharma and biotech companies cut their own R&D budgets and the complexity of clinical trials required to bring new molecules to market grows exponentially. Last week, private equity firm CCMP Capital Advisors, LLC sold a majority interest in Medpace, Inc. to European PE firm, Cinven. The price was a total consideration of $915 million “plus certain cash inflows relating to the period of ownership.” Medpace focuses its CRO programs on small to mid-sized biotech, pharma and medical device companies, with significant expertise in therapeutic areas such as metabolic, cardiovascular, oncology, anti-viral/anti-infective, central nervous system and medical devices. Cinven has been looking for opportunities to get into the CRO industry, and is hoping to expand Medpace’s presence across Europe and Asia.......Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.

 

In the Pipeline
Anything to do with blood diagnostics brings investors running, it seems. Just think of the $4.15 billion that The Carlyle Group (NASDAQ: CG) paid for Johnson & Johnson’s (NYSE: JNJ) Ortho-Clinical Diagnostics in January. Smaller deals pop up frequently, and last week Cheetah Medical of Newton Center, Massachusetts announced closing a round of fundraising totaling $9 million. Cheetah makes and markets the Cheetah NICOM Hemodynamic Management System, which offers a non-invasive means to measure key parameters in the blood. Fletcher Spaght Ventures led the round, joined by Springfield Investment Management, MVM Life Science Partners, Robert Bosch Venture Capital and Ascension Health Ventures.....Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.

 

NEW - The Health Care Services Acquisition Report, 20th Edition - Preorder Today!

Deals have been made. The 2014 Health Care Services Acquisition Report contains private deals in this market that are frequently too small to make into financial press. Take advantage of our limited 2-for-1 offer - Preorder The 2014 Health Services Care Acquisition Report by March 31st and receive The 2013 Health Care Services Acquisition Report FREE ($595 value)! Now that’s a deal! Go to http://www.levinassociates.com/landing/har20order or call 800-248-1668 to preorder today.

 

Upcoming Interactive Webcast:
Urgent Care Centers: An Entrepreneurial Opportunity

Thursday, March 27, 2014, 1:00 pm ET

Urgent care centers are popping up in cities and all over suburbia. Hospitals are getting into the business, doctors have started their own, and strategic buyers (provider groups, venture capitalists, private equity firms) are licking their lips. Buyers are swallowing up small centers in order to build large-scale platforms in this increasingly profitable sector. Some current owners are looking to grow these businesses to a national level. Go to http://www.levinassociates.com/conferences/1403b-online-conference or call 800-248-1668 to register.

 

Around the Web in Health Care M&A...Click here to see more

 
Webcast Calendar...Click here to see more

 

Upcoming Conference Partnerships... Click here to see more